Bristol-Myer Squibb has only just won FDA approval for its CAR-T Breyanzi in large B-cell lymphoma (LBCL), but is already eyeing an expansion into earlier-line therapy that could overtake rival ...

Philadelphia’s front four overwhelmed Kansas City’s front five in that matchup, and Mahomes finished the game with a ...